|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.78 USD | -4.69% |
|
-6.23% | -0.21% |
| 05-06 | Arcus Biosciences, Inc., Q1 2026 Earnings Call, May 05, 2026 | |
| 05-05 | Arcus Biosciences Q1 Loss Narrows, Revenue Falls | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.99B | - | ||||
| 41.67B | |||||
| 32.6B | |||||
| 30.97B | - | - | - | - | - |
| 28.23B | |||||
| 26.41B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition